Publications by authors named "Michael Seet"

Claim this Profile
M
Mechanism of Allosteric Inhibition of the Enzyme IspD by Three Different Classes of Ligands.
Anatol Schwab, Boris Illarionov, Annika Frank, Andrea Kunfermann, Michael Seet

ACS Chem Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities.
Matthias C Witschel, Matthias Rottmann, Anatol Schwab, Ubolsree Leartsakulpanich, Penchit Chitnumsub, Michael Seet

J Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deorphaning pyrrolopyrazines as potent multi-target antimalarial agents.
Daniel Reker, Michael Seet, Max Pillong, Christian P Koch, Petra Schneider

Angew Chem Int Ed Engl· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudilins: halogenated, allosteric inhibitors of the non-mevalonate pathway enzyme IspD.
Andrea Kunfermann, Matthias Witschel, Boris Illarionov, René Martin, Matthias Rottmann, Michael Seet

Angew Chem Int Ed Engl· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of the herbicidal target IspD: allosteric site binding.
Matthias C Witschel, H Wolfgang Höffken, Michael Seet, Liliana Parra, Thomas Mietzner

Angew Chem Int Ed Engl· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitors of the kinase IspE: structure-activity relationships and co-crystal structure analysis.
Anna K H Hirsch, Magnus S Alphey, Susan Lauw, Michael Seet, Luzi Barandun

Org Biomol Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis